MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 41 filers reported holding MEDICINES CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,305,000 | +16.8% | 2,350,000 | 0.0% | 0.01% | +14.3% |
| Q1 2019 | $1,973,000 | +6.4% | 2,350,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $1,854,000 | -15.5% | 2,350,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $2,194,000 | -27.4% | 2,350,000 | -21.7% | 0.01% | -33.3% |
| Q2 2018 | $3,022,000 | +5.1% | 3,000,000 | 0.0% | 0.01% | -7.7% |
| Q1 2018 | $2,874,000 | – | 3,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |